The Texas Biomedical Research Institute in San Antonio, has obtained more than $23 million in funding for an HIV vaccine they’re developing in conjunction with medical experts from the U.S. and Europe.

Stem cell research has progressed in recent years, but the potential benefits from these advancements are struggling to find a place in the healthcare market. A report by GBI Research found that while stem cells are in the end stages of development for use, they still face an uphill climb to being used in healthcare. 

A new study from the journal Addiction says all of those so-called benefits associated with alcohol are useless or non-existent because it causes at least seven different types of cancer all throughout the body, and drinking even moderately can apparently increase your risk of developing the disease.

Researchers have developed neuroprotective compounds that may be capable of preventing seizures in people who suffer from epilepsy.

Scientists from the University of Sussex have developed a new protein, comparable to the protein that causes Alzheimer’s, in an effort to better understand why the disease causes nerve cells to die. 

More is not always better, especially in the healthcare industry. Researchers from the University of Pittsburgh School of Medicine have found as the number of patients admitted into trauma centers increase, the number of patients dying decreases twofold. 

Top experts from Cleveland Clinic, Microsoft and Case Western have introduced the latest in healthcare technology, holograms for medical education.  

With 21,000 new diagnoses and 14,000 deaths, ovarian cancer is undoubtedly one of the most lethal cancers. A major factor leading to the high mortality rate is the fact that the cancer is not detected until the later stages and has a 75 percent chance of returning. Faced with these staggering odds, researchers at the Mayo Clinic Center for Individualized Medicine have been able to develop a new way to tract and treat ovarian cancer.